Jack Henry & Associates (NASDAQ:JKHY) Lifted to “Buy” at StockNews.com

Jack Henry & Associates (NASDAQ:JKHY) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday.

A number of other equities research analysts have also recently issued reports on the company. Wolfe Research began coverage on Jack Henry & Associates in a report on Thursday, March 7th. They set a “peer perform” rating for the company. TheStreet upgraded Jack Henry & Associates from a “c+” rating to a “b-” rating in a research note on Friday, December 29th. Evercore ISI upped their target price on Jack Henry & Associates from $157.00 to $172.00 and gave the company an “in-line” rating in a research report on Tuesday, March 26th. William Blair restated an “outperform” rating on shares of Jack Henry & Associates in a research report on Wednesday, February 7th. Finally, Royal Bank of Canada raised their price target on Jack Henry & Associates from $161.00 to $181.00 and gave the stock a “sector perform” rating in a research report on Thursday, February 8th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $171.58.

Jack Henry & Associates Trading Down 0.2 %

Shares of NASDAQ:JKHY opened at $170.05 on Friday. Jack Henry & Associates has a 12-month low of $136.57 and a 12-month high of $178.37. The stock has a market cap of $12.39 billion, a PE ratio of 33.28, a P/E/G ratio of 4.02 and a beta of 0.66. The business has a 50 day moving average of $171.77 and a 200-day moving average of $161.87. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 0.15.

Jack Henry & Associates (NASDAQ:JKHY) last issued its quarterly earnings data on Wednesday, February 7th. The technology company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.14 by $0.12. Jack Henry & Associates had a return on equity of 22.67% and a net margin of 17.26%. The company had revenue of $545.70 million during the quarter, compared to analysts’ expectations of $540.34 million. During the same quarter in the previous year, the company posted $1.10 earnings per share. The business’s revenue was up 8.0% on a year-over-year basis. As a group, equities research analysts forecast that Jack Henry & Associates will post 5.11 earnings per share for the current year.

Institutional Trading of Jack Henry & Associates

Large investors have recently bought and sold shares of the business. NBC Securities Inc. acquired a new stake in Jack Henry & Associates in the third quarter valued at about $30,000. Planned Solutions Inc. acquired a new stake in shares of Jack Henry & Associates during the fourth quarter valued at about $33,000. Harbour Investments Inc. boosted its stake in shares of Jack Henry & Associates by 62.2% during the fourth quarter. Harbour Investments Inc. now owns 206 shares of the technology company’s stock valued at $34,000 after purchasing an additional 79 shares in the last quarter. Anchor Investment Management LLC acquired a new stake in shares of Jack Henry & Associates during the fourth quarter valued at about $35,000. Finally, West Tower Group LLC boosted its stake in shares of Jack Henry & Associates by 602.8% during the fourth quarter. West Tower Group LLC now owns 253 shares of the technology company’s stock valued at $41,000 after purchasing an additional 217 shares in the last quarter. 98.75% of the stock is owned by institutional investors and hedge funds.

About Jack Henry & Associates

Jack Henry & Associates, Inc, a financial technology company that connects people and financial institutions through technology solutions and payment processing services that reduce the barriers to financial health. It operates through four segments: Core, Payments, Complementary, and Corporate and Other.